Joseph Feczko

Joseph M.
Feczko is currently the Chairman at Cardoz Pharmaceuticals AB, Director at International Longevity Center, Director at Research!America, Director at Foundation for the National Institutes of Health, Inc., Director at Academic Alliance Foundation, Director at Accordia Global Health Foundation, Director-Trachoma Technical Expert Committee at The Task Force for Global Health, Inc., Trustee at The New York Academy of Medicine, and Member-Pharmaceutical Drug Forum at National Academy of Medicine (United States).
Previously, Dr. Feczko served as an Independent Director at Keryx Biopharmaceuticals, Inc. from 2010 to 2016, Independent Director at ChemoCentryx, Inc. from 2012 to 2022, Medical Director-Research & Development at GSK Plc, Director-Technology Strategy Board at United Kingdom Department for Business, Innovation & Skills, Independent Director at Cytheris SA, Director-Clinical Development & Operations at Pfizer Ltd. from 1982 to 1992, Director at RSPR Pharma AB, Director at Adenium Biotech ApS, Chief Medical Officer & Senior Vice President at Pfizer Inc. from 1982 to 2009, Member-Governors Board at Innovate UK, Member-Supervisory Board at Amsterdam Molecular Therapeutics (AMT) Holding NV from 2010 to 2013, and Member-Supervisory Board at uniQure NV from 2012 to 2016.
Dr. Feczko obtained an undergraduate degree from Loyola University of Chicago and a doctorate degree from the University of Illinois College of Medicine.